Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20


Clinical outcomes of patients with epithelioid sarcomas: impact and management of nodal metastasis.

Outani H, Imura Y, Tanaka T, Takenaka S, Oshima K, Hamada K, Kakunaga S, Joyama S, Naka N, Kudawara I, Ueda T, Araki N, Yoshikawa H.

Int J Clin Oncol. 2018 Feb;23(1):181-188. doi: 10.1007/s10147-017-1179-x. Epub 2017 Aug 10.


Treatment outcomes of Japanese patients with Ewing sarcoma: differences between skeletal and extraskeletal Ewing sarcoma.

Takenaka S, Naka N, Obata H, Joyama S, Hamada K, Imura Y, Kakunaga S, Aoki Y, Ueda T, Araki N, Yoshikawa H.

Jpn J Clin Oncol. 2016 Jun;46(6):522-8. doi: 10.1093/jjco/hyw032. Epub 2016 Mar 23.


Objective tumor response to denosumab in patients with giant cell tumor of bone: a multicenter phase II trial.

Ueda T, Morioka H, Nishida Y, Kakunaga S, Tsuchiya H, Matsumoto Y, Asami Y, Inoue T, Yoneda T.

Ann Oncol. 2015 Oct;26(10):2149-54. doi: 10.1093/annonc/mdv307. Epub 2015 Jul 23.


Development and external validation of nomograms predicting distant metastases and overall survival after neoadjuvant chemotherapy and surgery for patients with nonmetastatic osteosarcoma: A multi-institutional study.

Ogura K, Fujiwara T, Yasunaga H, Matsui H, Jeon DG, Cho WH, Hiraga H, Ishii T, Yonemoto T, Kamoda H, Ozaki T, Kozawa E, Nishida Y, Morioka H, Hiruma T, Kakunaga S, Ueda T, Tsuda Y, Kawano H, Kawai A.

Cancer. 2015 Nov 1;121(21):3844-52. doi: 10.1002/cncr.29575. Epub 2015 Jul 20.


Comparison of clinical and functional outcome between surgical treatment and carbon ion radiotherapy for pelvic chondrosarcoma.

Outani H, Hamada K, Imura Y, Oshima K, Sotobori T, Demizu Y, Kakunaga S, Joyama S, Imai R, Okimoto T, Naka N, Kudawara I, Ueda T, Araki N, Kamada T, Yoshikawa H.

Int J Clin Oncol. 2016 Feb;21(1):186-93. doi: 10.1007/s10147-015-0870-z. Epub 2015 Jul 7.


Phase I and pharmacokinetic study of trabectedin, a DNA minor groove binder, administered as a 24-h continuous infusion in Japanese patients with soft tissue sarcoma.

Ueda T, Kakunaga S, Ando M, Yonemori K, Sugiura H, Yamada K, Kawai A.

Invest New Drugs. 2014 Aug;32(4):691-9. doi: 10.1007/s10637-014-0094-5. Epub 2014 Apr 3.


Additive Influence of Extracellular pH, Oxygen Tension, and Pressure on Invasiveness and Survival of Human Osteosarcoma Cells.

Matsubara T, Diresta GR, Kakunaga S, Li D, Healey JH.

Front Oncol. 2013 Jul 29;3:199. doi: 10.3389/fonc.2013.00199. eCollection 2013.


Primary amyloidoma in epidural and paravertebral space of the lumbar spine.

Aono H, Kakunaga S, Koide S, Tobimatsu H, Kuroda M, Kudawara I, Mori K, Konishi E, Ueda T.

Spine J. 2013 Oct;13(10):e27-30. doi: 10.1016/j.spinee.2013.05.051. Epub 2013 Jul 23.


Constrained total hip megaprosthesis for primary periacetabular tumors.

Ueda T, Kakunaga S, Takenaka S, Araki N, Yoshikawa H.

Clin Orthop Relat Res. 2013 Mar;471(3):741-9. doi: 10.1007/s11999-012-2625-8.


Intramedullary spinal cord metastasis following spontaneous malignant transformation from giant cell tumor of bone 16 years after pulmonary metastasis.

Ozaki T, Ueda T, Wakamatsu T, Kakunaga S, Iwasa Y, Konishi E, Mano M, Moriuchi S.

J Orthop Sci. 2011 Jan;16(1):119-24. doi: 10.1007/s00776-010-0002-6. Epub 2011 Jan 20. No abstract available.


Eleven cases of cardiac metastases from soft-tissue sarcomas.

Takenaka S, Hashimoto N, Araki N, Hamada K, Naka N, Joyama S, Kakunaga S, Ueda T, Myoui A, Yoshikawa H.

Jpn J Clin Oncol. 2011 Apr;41(4):514-8. doi: 10.1093/jjco/hyq246. Epub 2011 Jan 19.


Evaluation of delayed 18F-FDG PET in differential diagnosis for malignant soft-tissue tumors.

Hamada K, Tomita Y, Ueda T, Enomoto K, Kakunaga S, Myoui A, Higuchi I, Yoshikawa H, Hatazawa J.

Ann Nucl Med. 2006 Dec;20(10):671-5.


A novel type of EWS-CHOP fusion gene in myxoid liposarcoma.

Matsui Y, Ueda T, Kubo T, Hasegawa T, Tomita Y, Okamoto M, Myoui A, Kakunaga S, Yasui N, Yoshikawa H.

Biochem Biophys Res Commun. 2006 Sep 22;348(2):437-40. Epub 2006 Jul 28.


Inhibition of cell movement and proliferation by cell-cell contact-induced interaction of Necl-5 with nectin-3.

Fujito T, Ikeda W, Kakunaga S, Minami Y, Kajita M, Sakamoto Y, Monden M, Takai Y.

J Cell Biol. 2005 Oct 10;171(1):165-73.


Enhancement of serum- and platelet-derived growth factor-induced cell proliferation by Necl-5/Tage4/poliovirus receptor/CD155 through the Ras-Raf-MEK-ERK signaling.

Kakunaga S, Ikeda W, Shingai T, Fujito T, Yamada A, Minami Y, Imai T, Takai Y.

J Biol Chem. 2004 Aug 27;279(35):36419-25. Epub 2004 Jun 22.


Nectin-like molecule-5/Tage4 enhances cell migration in an integrin-dependent, Nectin-3-independent manner.

Ikeda W, Kakunaga S, Takekuni K, Shingai T, Satoh K, Morimoto K, Takeuchi M, Imai T, Takai Y.

J Biol Chem. 2004 Apr 23;279(17):18015-25. Epub 2004 Feb 9.


Implications of nectin-like molecule-2/IGSF4/RA175/SgIGSF/TSLC1/SynCAM1 in cell-cell adhesion and transmembrane protein localization in epithelial cells.

Shingai T, Ikeda W, Kakunaga S, Morimoto K, Takekuni K, Itoh S, Satoh K, Takeuchi M, Imai T, Monden M, Takai Y.

J Biol Chem. 2003 Sep 12;278(37):35421-7. Epub 2003 Jun 25.


Tage4/Nectin-like molecule-5 heterophilically trans-interacts with cell adhesion molecule Nectin-3 and enhances cell migration.

Ikeda W, Kakunaga S, Itoh S, Shingai T, Takekuni K, Satoh K, Inoue Y, Hamaguchi A, Morimoto K, Takeuchi M, Imai T, Takai Y.

J Biol Chem. 2003 Jul 25;278(30):28167-72. Epub 2003 May 11.


Role of nectin in formation of E-cadherin-based adherens junctions in keratinocytes: analysis with the N-cadherin dominant negative mutant.

Tanaka Y, Nakanishi H, Kakunaga S, Okabe N, Kawakatsu T, Shimizu K, Takai Y.

Mol Biol Cell. 2003 Apr;14(4):1597-609.

Supplemental Content

Loading ...
Support Center